Renal cell carcinoma (RCC) is one of the most insensitive urologic tumors to either radiotherapy or anticancer chemotherapy. Several reports have shown that interferon (IFN) is the agent of great promise to treat advanced RCC. However, the effectiveness of IFN is limited.1) Eighteen patients with advanced RCC were treated by IL2. Antitumor effects were evaluated according to immunological parameters and survival rates.
|Number of pages||2|
|Journal||Annals of Cancer Research and Therapy|
|Publication status||Published - 1993|
- Renal cell carcinoma
ASJC Scopus subject areas
- Cancer Research
- Pharmacology (medical)